Analyst firms · J.P. Morgan · RAPT
J.P. Morgan RAPT price target and rating history
RAPT Therapeutics Inc. (RAPT) · Health Care
J.P. Morgan rates RAPT Therapeutics Inc. (RAPT) Underweight with a $15 price target, as of its latest action on Nov 11, 2024. It has published 3 rating actions on RAPT since December 2021, including 0 upgrades and 2 downgrades.
- Current rating
- Underweight
- Price target
- $15
- Median target, all firms
- Too few
- Actions on RAPT
- 3
J.P. Morgan price target on RAPT
Every J.P. Morgan rating on RAPT
- Nov 11, 2024
- Feb 21, 2024
- Dec 9, 2021
Questions about J.P. Morgan and RAPT
- What is J.P. Morgan's price target for RAPT?
- J.P. Morgan's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $15, from its action on Feb 21, 2024.
- What is J.P. Morgan's rating on RAPT?
- J.P. Morgan rates RAPT Underweight, a bearish rating, as of Nov 11, 2024.
- When did J.P. Morgan last change its view on RAPT?
- On Nov 11, 2024, J.P. Morgan downgrades to Underweight from Neutral.
More RAPT rating histories
All J.P. Morgan ratingsRAPT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.